Navigation Links
Type 2 Diabetes Could Be Tackled Using Curry Colouring and Fat Mix

A new treatment has been developed by an immunologist Dr Brendan O'Sullivan of Brisbane, for Type 2 diabetes, which will put a stop to the skyrocketing rates// of medicines that is available for diabetes in Australia.

The Senior Research Officer and his team at UQ's Centre for Immunology and Cancer Research (CICR) are developing a drug that targets liver cells to prevent their inflammation in obesity -- a common precursor to diabetes, reports

Dr O'Sullivan has received a three-year $150,000 Smart State Fellowship from the State Government to explore potential diabetes treatments.

Arthritis Queensland and the CICR will also contribute a further $150,000 each during the project.

People with Type 2 diabetes cannot produce enough insulin or do not use the insulin they produce properly.

Insulin is a hormone produced by the pancreas, which moves sugar from the food we eat into the body's cells.

Dr O'Sullivan said his technique involved coating treatment drugs in absorbable fat, which formed an injectable dose that could last up to one week.

"One of the drugs we're using is curcumin, which is basically the yellow compound that you see in curries, which is an anti-inflammatory compound," Dr O'Sullivan said.

"The idea is to encapsulate that compound and then deliver it to the liver cells to prevent them from producing all these inflammatory compounds."

Early results show his method works in mice but he said his grant would validate the best method to use in human trials.

The 36-year-old from Kedron said that, if successful, the treatment could combat other diseases such as heart disease, osteoarthritis, rheumatoid arthritis and lupus, an autoimmune disease against the skin.

His Fellowship will pay for staff, lab and research work.

UQ's Deputy Vice-Chancellor (Research) Professor David Siddle said Dr O'Sull ivan's project was one of many leading-edge CICR projects.

"Our determined immunologists are tackling some of society's worst diseases with great science," Professor Siddle said.


Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Diabetes on the rise
5. Irregular Periods Linked to Diabetes
6. Cinnamon combats Diabetes
7. Good News For Women With Gestational Diabetes
8. Processed Meat, Diabetes connection Found
9. Pancreatic Cancer may be linked to Diabetes
10. Gestational Diabetes linked to Chromosomal defici
11. A way to slow the progression of Type 1 Diabetes
Post Your Comments:

(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: